Showing results (41-50 of 319) with videos related to
Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancerEverett E Vokes, Jeffrey Crawford, Jeffrey Bogart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancerEzra E W Cohen, Daniel J Haraf, Rangesh Kunnavakkam, et al.Archives of Otolaryngology--Head & Neck Surgery|September 23, 2009
Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancerAlexander Langerman, Richard Comstock, Sheela Konda, et al.Cancer|July 13, 2002
An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neckMarcy A List, Judith Lee Rutherford, John Stracks, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neckDenis Soulieres, Neil N Senzer, Everett E Vokes, et al.Annals of Translational Medicine|February 10, 2023
New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approachTiffany H Leung, James C Ho, Aya El Helali, et al.Cancer Chemotherapy and Pharmacology|July 12, 2002
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancerChristopher W Ryan, Everett E Vokes, Nicholas J Vogelzang, et al.Oral Oncology|July 10, 2009
Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neckEzra Eddy Wyssam Cohen, Anna B Halpern, Kristen Kasza, et al.International Journal of Oncology|April 6, 2006
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancersPhilip P Connell, Krishanthi Jayathilaka, Daniel J Haraf, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanomaThomas F Gajewski, Jeffrey Sosman, Stanton L Gerson, et al.Pageof 32